Skip to main content
Caplight Logo









Corryn Biotechnologies

Corryn Biotechnologies

Private
SwanseaHealthcare & Life Scienceshttps://dermaweave.co.uk/

Last Round

Seed

Apr 1, 2026

Total Funding Raised

$1.98M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Corryn Biotechnologies is a medical technology company developing a handheld device to fabricate and deposit biomimetic fibrous wound dressings directly upon wound sites at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

electrospinningwound dressingpoint-of-caremedical deviceresorbable dressingbiomaterialscosmetic aftercarerazor-and-bladewound caremedtechtissue engineeringdermatology technologyconsumable cartridgescontactless dressing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Corryn Biotechnologies Comparables

Compare Corryn Biotechnologies with similar companies based on industry and business-model similarity.

Corryn Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanomedic Technologies
89%
Matregenix
85%
Atreon Orthopedics
73%

Corryn Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 1, 2026
SeedSep 17, 2024
GrantMay 14, 2024
GrantJul 3, 2023
GrantMay 1, 2023
Grant
Jul 7, 2021

Key People

Founding team and executive leadership

Fabio Zomer Volpato

Co-Founder and Chief Operations Officer

Founding Team

Luke Burke

Chief Executive Officer

Executive Team

Corryn Biotechnologies Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2026

    Added 1 new job posting, representing 25% of headcount.

  • Apr 2, 2026

    $635K raised in early funding.

Corryn Biotechnologies Filings

Explore SEC and related filing metadata, where available.

Corryn Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Corryn Biotechnologies's valuation, stock price, and market status.

Is Corryn Biotechnologies a public or private company?

Corryn Biotechnologies is a private company.

What is the current stock price of Corryn Biotechnologies?

Corryn Biotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is Corryn Biotechnologies worth (valuation)?

Valuation information for Corryn Biotechnologies is not publicly available.

Can I buy Corryn Biotechnologies stock?

Corryn Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Corryn Biotechnologies's last funding round?

Corryn Biotechnologies's most recent funding round was Early Funding on April 2, 2026.

Who are the main investors in Corryn Biotechnologies?

Key investors in Corryn Biotechnologies include Sapphire Capital Partners.

Will Corryn Biotechnologies IPO soon?

No public IPO plans have been announced for Corryn Biotechnologies.

How can I track Corryn Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Corryn Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSwansea
Employee Range4
Year Founded2021
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?